| The pan-Bcl-2 inhibitor (−)-gossypol triggers autophagic cell death in malignant glioma V Voss, C Senft, V Lang, MW Ronellenfitsch, JP Steinbach, V Seifert, ... Molecular cancer research 8 (7), 1002-1016, 2010 | 207 | 2010 |
| Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The … U Herrlinger, N Schäfer, JP Steinbach, A Weyerbrock, P Hau, ... Journal of Clinical Oncology 34 (14), 1611-1619, 2016 | 197 | 2016 |
| mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy M Weiler, J Blaes, S Pusch, F Sahm, M Czabanka, S Luger, L Bunse, ... Proceedings of the National Academy of Sciences 111 (1), 409-414, 2014 | 180 | 2014 |
| Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases PN Harter, S Bernatz, A Scholz, PS Zeiner, J Zinke, M Kiyose, S Blasel, ... Oncotarget 6 (38), 40836, 2015 | 128 | 2015 |
| Synthesis of cytochrome C oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell … C Wanka, DP Brucker, O Bähr, M Ronellenfitsch, M Weller, JP Steinbach, ... Oncogene 31 (33), 3764-3776, 2012 | 69 | 2012 |
| Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine KJ Wenger, M Wagner, SJ You, K Franz, PN Harter, MC Burger, M Voss, ... Oncology letters 14 (1), 1141-1146, 2017 | 66 | 2017 |
| Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease MC Burger, MW Ronellenfitsch, NI Lorenz, M Wagner, M Voss, D Capper, ... Oncology reports 38 (6), 3291-3296, 2017 | 62 | 2017 |
| ERGO2: A Prospective, Randomized Trial of Calorie-Restricted Ketogenic Diet and Fasting in Addition to Reirradiation for Malignant Glioma M Voss, M Wagner, N von Mettenheim, PN Harter, KJ Wenger, K Franz, ... International Journal of Radiation Oncology* Biology* Physics 108 (4), 987-995, 2020 | 60 | 2020 |
| Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells … MW Ronellenfitsch, DP Brucker, MC Burger, S Wolking, F Tritschler, ... Brain 132 (6), 1509-1522, 2009 | 58 | 2009 |
| Serine-dependent redox homeostasis regulates glioblastoma cell survival AL Engel, NI Lorenz, K Klann, C Münch, C Depner, JP Steinbach, ... British journal of cancer 122 (9), 1391-1398, 2020 | 50 | 2020 |
| The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma M Foltyn, AL Luger, NI Lorenz, B Sauer, M Mittelbronn, PN Harter, ... British journal of cancer 120 (5), 481-487, 2019 | 47 | 2019 |
| The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis C Tehranian, L Fankhauser, PN Harter, CDH Ratcliffe, PS Zeiner, ... Neuro-oncology 24 (2), 213-225, 2022 | 45 | 2022 |
| Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: implications of using tet-inducible systems AL Luger, B Sauer, NI Lorenz, AL Engel, Y Braun, M Voss, PN Harter, ... International journal of molecular sciences 19 (5), 1504, 2018 | 44 | 2018 |
| Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas L Jennewein, MW Ronellenfitsch, P Antonietti, EI Ilina, J Jung, D Stadel, ... Oncotarget 7 (15), 20016, 2016 | 38 | 2016 |
| Treatment of refractory and superrefractory status epilepticus with topiramate: a cohort study of 106 patients and a review of the literature A Fechner, K Hubert, K Jahnke, S Knake, J Konczalla, K Menzler, ... Epilepsia 60 (12), 2448-2458, 2019 | 37 | 2019 |
| Personalized translational epilepsy research—Novel approaches and future perspectives: Part I: Clinical and network analysis approaches F Rosenow, N van Alphen, A Becker, A Chiocchetti, R Deichmann, ... Epilepsy & Behavior 76, 13-18, 2017 | 36 | 2017 |
| Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death AL Thiepold, NI Lorenz, M Foltyn, AL Engel, I Divé, H Urban, S Heller, ... Brain 140 (10), 2623-2638, 2017 | 36 | 2017 |
| Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives MW Ronellenfitsch, JP Steinbach, W Wick Targeted oncology 5, 183-191, 2010 | 34 | 2010 |
| Perioperative cerebral ischemia promote infiltrative recurrence in glioblastoma AL Thiepold, S Luger, M Wagner, N Filmann, MW Ronellenfitsch, ... Oncotarget 6 (16), 14537, 2015 | 31 | 2015 |
| CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival PS Zeiner, J Zinke, DJ Kowalewski, S Bernatz, J Tichy, MW Ronellenfitsch, ... Acta neuropathologica communications 6 (1), 1-16, 2018 | 29 | 2018 |
